Medicare Advantage provider Clover Health (CLOV) is both despised and loved, depending on whom you ask. The newly-public company has earned a prized status among top meme stocks. But the company is also facing significant backlash in the form of lawsuits after a scathing report from short-seller firm Hindenburg Research. [Read more: Clover Health CEO speaks out for first time on hospital controversies] It’s something the company’s normally media-shy CEO, Vivek Garipalli, recently discussed in… Source link
Read More »‘It’s probably not a bad thing if Clover does well,’ CEO Garipalli says
